Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhengzhou Gensciences Biotechnology
Nantong, Jiangsu, China
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Gensciences has four core clinical programs in hemophilia A, B, and inhibitors, including the first long-acting recombinant Factor VIII product in China (FRSW107, Phase III and registration), a once-weekly ultra-long-acting FVIII (FRSW117, Phase III, FDA orphan drug), world’s first ultra-long-acting recombinant activated Factor VII (SS109, Phase II/III prep), and an ultra-long-acting Factor IX (SS327, IND approved)[5][6][7][8]. Clinical results indicate strong efficacy, robust bleeding prevention, and improved dosing convenience, with significant regulatory advances both in China and internationally.
- Therapeutic areas
- Hematology
- Modalities
- Recombinant proteinFc fusion proteinMonoclonal antibodyPEGylated recombinant protein
- Industry
- Biotech
02
Partnerships
Multiple multinational pharma collaborations (actively seeking partners, esp. in hemophilia and global commercialization)[2]
Beyond the preview
Go deeper on Zhengzhou Gensciences Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhengzhou Gensciences Biotechnology.